Bone marrow-derived mononuclear cell therapy for non-ischemic dilated cardiomyopathy: A meta-analysis
European Journal of Clinical Investigation | Jan 27, 2018
Wen Y, et al. - As a part of this research, the effects of bone marrow-derived mononuclear cell (BMMNCs) transplantation on left ventricular ejection fraction (LVEF) were comprehensively scrutinized in patients with non-ischemic dilated cardiomyopathy (DCM). As per the results, BMMNCs transplantation exhibited a link with a moderate, yet notable, improvement in LVEF in the study cohort.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
